STEFAN BRECKE: Open Payments
NPI 1457318040 · SUFFOLK, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,872 in 88 payments from 25 companies in 2025. Trend: 2023 $1,803 · 2024 $1,807 · 2025 $1,872
Food & beverage: $1,872
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 12 | $244 |
| Novo Nordisk Inc | 12 | $231 |
| AstraZeneca Pharmaceuticals LP | 9 | $187 |
| GlaxoSmithKline, LLC. | 8 | $169 |
| ABBVIE INC. | 8 | $159 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $118 |
| SHIELD THERAPEUTICS INC | 2 | $98 |
| Xeris Pharmaceuticals, Inc. | 2 | $92 |
| Verona Pharma, Inc. | 3 | $55 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $49 |
Products named: NURTEC ODT, TRELEGY ELLIPTA, ELIQUIS, ACCRUFER, AIRSUPRA, Wegovy, Ozempic, JARDIANCE.
Industry payments across VA — which companies pay providers there.
